3Indexed trials
drug · Product Intelligence
Risperidone ISM 100 mg
Pipeline Intelligence
Risperidone ISM 100 mg: 3 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
1Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT03527186Rovi Pharmaceuticals Laboratories · schizophreniaPHASE1
NCT03870880Rovi Pharmaceuticals Laboratories · schizophreniaPHASE3
NCT05179525Rovi Pharmaceuticals Laboratories · schizophreniaPHASE1
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.